Logo image
Sign in
Back
Inflammation in atherosclerosis: Some thoughts about acute coronary syndromes
Journal article   Open access

Inflammation in atherosclerosis: Some thoughts about acute coronary syndromes

A. R. Lucas, R. Korol and C. J. Pepine
Circulation, Vol.113(17)
2006
DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.601492

Abstract

acetylsalicylic acid aldosterone antagonist angiotensin receptor antagonist antiangina pectoris agent anticoagulant agent antilipemic agent antithrombocytic agent beta adrenergic receptor blocking agent C reactive protein calcium antagonist clopidogrel dihydropyridine derivative dipeptidyl carboxypeptidase inhibitor eplerenone ezetimibe fibric acid derivative fibrinogen receptor antagonist heparin hydroxymethylglutaryl coenzyme A reductase inhibitor interleukin 6 low molecular weight heparin meloxicam nicotinic acid nitrate perindopril peroxisome proliferator activated receptor agonist pioglitazone spironolactone statine derivative unindexed drug fibrinolytic agent acute coronary syndrome aged antiinflammatory activity atherosclerosis bleeding blood clotting blood vessel injury case report cell infiltration clinical trial cytokine production diabetes mellitus environmental factor female heart infarction heredity human immune response inflammation insulin resistance lipid metabolism metabolic syndrome X nonhuman percutaneous coronary intervention priority journal renin angiotensin aldosterone system short survey stent vascular endothelium acute disease coronary artery disease drug effect review Antilipemic Agents Coronary Disease Fibrinolytic Agents Humans Platelet Aggregation Inhibitors Renin-Angiotensin System Stents
url
https://doi.org/10.1161/CIRCULATIONAHA.105.601492View
Published (Version of record) Open

Metrics

1 Record Views

Details